Philip Philip, MD
Enriched profileProfessor of Oncology and Pharmacology (Wayne State University); Physician, Medical Oncology (Henry Ford Health) · Henry Ford Health
Philip Philip is Professor of Oncology and Pharmacology (Wayne State University); Physician, Medical Oncology (Henry Ford Health) at Henry Ford Health. OpenAlex indexes 407 publications with 18,404 citations (h-index 71).
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Philip A. Philip, MD PHD FRCP, is Professor of Oncology and Pharmacology (Wayne State University) at Henry Ford Health / Henry Ford Cancer Institute, Detroit, MI (clinical); Wayne State University School of Medicine, Department of Oncology (academic, tenured professor). The public record shows 407 publications with 18,404 citations (h-index 71), centered on Pancreatic and Hepatic Oncology Research, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics. It also documents industry payments reported by 38 companies, 1 NIH-funded awards (2011–2015).
- Most recent indexed publication: 2025 · Journal of the National Cancer Institute
- Top research focus: Pancreatic and Hepatic Oncology Research
- Open Payments reporting from 38 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 178.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Updated 14 Oct 2026
38 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Corcept TherapeuticsProgram year202515 payments$10,084openpaymentsdata.cms.gov ↗
- JAZZ PHARMACEUTICALS INC.Program year20252 payments
- Novocure Inc.Program year20252 payments
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
54.2%Factor Xa inhibitor54.2%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
45.8%Opioid Agonist45.8%Loperamide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
1 NIH research award on record, funded 2011–2015 per NIH RePORTER. The latest:
Congress activity
Updated 14 Oct 2026
46 congress contributions (2010–2026) across AACR, ASCO, SABCS per OpenAlex. The most recent:
- Abstract 6876: A novel PCNA inhibitor AOH1996 demonstrates pre-clinical efficacy in pancreatic ductal adenocarcinoma models
AACR Annual Meeting
AACR2025Co-author - Abstract 6909: Exportin 1 as a novel therapeutic target in gastroenteropancreatic neuroendocrine tumors
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Utilizing Patient Input in Rectal Cancer Trial Design.
Journal of the National Cancer Institute
Article2025 - Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.
JCO oncology advances
Article2025 - Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial.
Journal of clinical oncology
Clinical Trial2025 - SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.
Journal of clinical oncology
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/philip-philip-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/philip-agop-philip-1ba41a132
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
henryford.com/news/2022/01/philip-philip
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →henryford.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- PhD
Clinical Pharmacology and Pharmacogenetics, University of London (Guy's Hospital Medical School), UK
1986provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →provaeducation.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →provaeducation.com ↗
- Fellowship
Medical Oncology, University of Oxford, UK
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →henryford.com ↗ - Fellowship
Medical Oncology, MD Anderson Cancer Center, Houston, TX
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →henryford.com ↗ - Board Certified
Internal Medicine, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →provaeducation.com ↗ - Board Certified
Medical Oncology, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →provaeducation.com ↗ - FRCP
Fellow of the Royal College of Physicians (London)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →provaeducation.com ↗
Editorial & leadership roles
journal and society appointments- Chair
GI Committee, SWOG (Southwest Oncology Group, NCI-sponsored clinical trials consortium)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →henryford.com ↗ - Member
NCI Cancer Therapy Evaluation Program (CTEP) committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →henryford.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncology.med.wayne.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncology.med.wayne.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncology.med.wayne.edu ↗
Secondary affiliations
appointments beyond the home institution- GI and Neuroendocrine Multidisciplinary Team leader / former Vice President for Medical Affairs
Barbara Ann Karmanos Cancer Institute, Detroit, MI
2022provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncology.med.wayne.edu ↗ - Secondary faculty appointments
Departments of Internal Medicine and Pharmacology, Wayne State University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pharmacology.med.wayne.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology-central.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- "Dr. Philip Philip on Choosing the Right Treatment for Advanced Pancreatic Cancer Patients"
video interview, Targeted Oncology / OncLive
2015verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →targetedonc.com ↗ - "Pancreatic Cancer – Clarifying the Different Types"
WDIV Local 4 (Detroit) news segment, Karmanos Video Library
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →karmanos.org ↗ - "IN THE NEWS: Dr. Philip on pancreatic cancer awareness"
Karmanos News feature
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →karmanos.org ↗ - Contributing author/columnist profile
OncLive (Karmanos Cancer Center)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Lanfear, MD
Henry Ford Health
Marvin Eng, MD
Henry Ford Health
Karthikeyan Ananthasubramaniam, MD
Henry Ford Health
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH